1.1301

1.81% 0.0201

Pre-market: 1.11 -0.0201 -1.78%

Lexaria Bioscience Corp (LEXX)

Overview News Price History Financials Discussions Forecast Stock Split

Lexaria Bioscience Corp stock is traded at $1.1301, with a volume of 206.88K. It is up +1.81% in the last 24 hours and up +1.81% over the past month. Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Previous Close:

$1.11

Open:

$1.09

24h Volume:

206.88K

Relative Volume:

0.48

Market Cap:

$25.12M

Revenue:

$411.00K

Net Income/Loss:

$-4.85M

P/E Ratio:

-2.5684

EPS:

-0.44

Net Cash Flow:

$-4.88M

1W Performance:

+0.90%

1M Performance:

+1.81%

6M Performance:

+17.61%

1Y Performance:

-56.37%

1-Day Range:

$1.055

$1.17

1-Week Range:

$1.00

$1.17

52-Week Range:

$0.7749

$2.61

Lexaria Bioscience Corp Stock (LEXX) Company Profile

Name

Lexaria Bioscience Corp

Sector

Healthcare (1131)

Industry

Biotechnology (632)

Phone

250-765-6424

Address

100 - 740 MCCURDY ROAD, KELOWNA

Employee

Twitter

Next Earnings Date

2025-07-28

Latest SEC Filings

LEXX's Discussions on Twitter

Compare LEXX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LEXX Lexaria Bioscience Corp	1.1301	24.67M	411.00K	-4.85M	-4.88M	-0.44
VRTX Vertex Pharmaceuticals Inc	457.26	117.50B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	722.83	76.06B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.56	62.53B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	916.31	56.75B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	205.04	44.10B	447.02M	-1.18B	-906.14M	-6.1812

Lexaria Bioscience Corp Stock (LEXX) Latest News

01:57 AM

How Lexaria Bioscience Corp. Equity Warrant stock performs in high volatility markets2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser

01:57 AM

Dec 04, 2025

How Lexaria Bioscience Corp. Equity Warrant stock compares to growth peersJuly 2025 Setups & Verified Technical Signals - Newser

Dec 04, 2025

Dec 03, 2025

Is Lexaria Bioscience Corp. stock a safe haven assetTake Profit & Risk Adjusted Buy and Sell Alerts - Newser

Dec 03, 2025

Nov 29, 2025

Lexaria Bioscience Corp. (NASDAQ:LEXX): Are Analysts Optimistic? - Yahoo Finance

Nov 29, 2025

Lexaria Bioscience (NASDAQ:LEXX) Stock Rating Upgraded by Wall Street Zen - Defense World

Nov 29, 2025

Nov 28, 2025

Lexaria Bioscience Corp. SEC 10-K Report - TradingView

Nov 28, 2025

Lexaria Bioscience : Annual Report for Fiscal Year Ending 08-31, 2025 (Form 10-K) - marketscreener.com

Nov 28, 2025

Nov 27, 2025

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended - Investing News Network

Nov 27, 2025

Lexaria Bioscience Corp. Reports Earnings Results for the Full Year Ended August 31, 2025 - marketscreener.com

Nov 27, 2025

Nov 26, 2025

Lexaria Bioscience Corp Stock Analysis and ForecastVolatility Index Analysis & Unlock Long-Term Capital Growth Ideas - earlytimes.in

Nov 26, 2025

NexMetals Mining (NASDAQ:NEXM) vs. Lexaria Bioscience (OTCMKTS:LXRP) Financial Survey - Defense World

Nov 26, 2025

Nov 22, 2025

S&P 500, NASDAQ and Dow rise as Wall Street ends volatile week on higher side: M-tron Industries gains nea - The Economic Times

Nov 22, 2025

Nov 21, 2025